Show simple item record

dc.contributor.authorAhoua, Laurence
dc.contributor.authorGuenther, Gunar
dc.contributor.authorRouzioux, Christine
dc.contributor.authorPinoges, Loretxu
dc.contributor.authorAnguzu, Paul
dc.contributor.authorTaburet, Anne-Marie
dc.contributor.authorBalkan, Suna
dc.contributor.authorOlson, David M
dc.contributor.authorOlaro, Charles
dc.contributor.authorPujades-Rodríguez, Mar
dc.date.accessioned2012-04-24T16:25:40Z
dc.date.available2012-04-24T16:25:40Z
dc.date.issued2011-07-26
dc.identifier.citationBMC Pediatr 2011; 11:67en_GB
dc.identifier.issn1471-2431
dc.identifier.pmid21791095
dc.identifier.doi10.1186/1471-2431-11-67
dc.identifier.urihttp://hdl.handle.net/10144/220332
dc.description.abstractChildren living with HIV continue to be in urgent need of combined antiretroviral therapy (ART). Strategies to scale up and improve pediatric HIV care in resource-poor regions, especially in sub-Saharan Africa, require further research from these settings. We describe treatment outcomes in children treated in rural Uganda after 1 and 2 years of ART start.
dc.language.isoenen
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.biomedcentral.com/1471-2431/11/67en_GB
dc.rightsArchived with thanks to BMC Pediatrics Open Access policyen_GB
dc.subject.meshAnti-Retroviral Agentsen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshChilden_GB
dc.subject.meshChild, Preschoolen_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshCross-Sectional Studiesen_GB
dc.subject.meshDrug Resistance, Viralen_GB
dc.subject.meshDrug Therapy, Combinationen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshFollow-Up Studiesen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshRNA, Viralen_GB
dc.subject.meshRetrospective Studiesen_GB
dc.subject.meshReverse Transcriptase Inhibitorsen_GB
dc.subject.meshRural Populationen_GB
dc.subject.meshUgandaen_GB
dc.titleImmunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.en
dc.typeArticleen
dc.contributor.departmentClinical Research Department, Epicentre, Paris, France; Laboratory of Virology, Necker Hospital, Paris, France; Department of Operations, Médecins Sans Frontières, Arua, Uganda; Laboratory of Clinical Pharmacology, Bicêtre Hospital, Kremlin Bicêtre, France; Medical Department, Médecins Sans Frontières, Paris, France; Medical Department, Médecins Sans Frontières, New York, USA; Medical and Administrative Hospital Direction, Arua Regional Referral Hospital, Arua, Ugandaen_GB
dc.identifier.journalBMC Pediatricsen_GB
refterms.dateFOA2019-03-04T09:42:51Z
html.description.abstractChildren living with HIV continue to be in urgent need of combined antiretroviral therapy (ART). Strategies to scale up and improve pediatric HIV care in resource-poor regions, especially in sub-Saharan Africa, require further research from these settings. We describe treatment outcomes in children treated in rural Uganda after 1 and 2 years of ART start.


Files in this item

Thumbnail
Name:
110726_Immunovirological-respo ...
Size:
451.7Kb
Format:
PDF
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record